相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glibenclamide as a neuroprotective antidementia drug
Alexander Zubov et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2022)
Are thiazolidinediones a preferred drug treatment for type 2 diabetes?
Kathryn M. Hurren et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
Yanxing Chen et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
Thiazolidinediones: An In-Depth Study of Their Synthesis and Application to Medicinal Chemistry in the Treatment of Diabetes Mellitus
Nathan Long et al.
CHEMMEDCHEM (2021)
Effectiveness and safety of glibenclamide for stroke: protocol for a systematic review and meta-analysis
Lihong Wen et al.
BMJ OPEN (2021)
Intranasal insulin administration may be highly effective in improving cognitive function in mice with cognitive dysfunction by reversing brain insulin resistance
Hui Lv et al.
COGNITIVE NEURODYNAMICS (2020)
Nateglinide Exerts Neuroprotective Effects via Downregulation of HIF-1α/TIM-3 Inflammatory Pathway and Promotion of Caveolin-1 Expression in the Rat's Hippocampus Subjected to Focal Cerebral Ischemia/Reperfusion Injury
Muhammad Abd El-Latif Saad et al.
INFLAMMATION (2020)
Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
Jonathan Chang-Cheng Shieh et al.
MOLECULAR NEUROBIOLOGY (2020)
The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation
Makoto Ide et al.
PLOS ONE (2020)
Cognitive and metabolic outcomes of vildagliptin addition to the therapy in patients with type 2 diabetes mellitus: 26 week follow-up study
Esra Ates Bulut et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2020)
Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway
Rania G. Abdel-latif et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes
Carmen Hierro-Bujalance et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?
Qi Cheng et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Link between Diabetes and Alzheimer's Disease Due to the Shared Amyloid Aggregation and Deposition Involving Both Neurodegenerative Changes and Neurovascular Damages
Gabriela Dumitrita Stanciu et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Relationships between memory decline and the use of metformin or DPP4 inhibitors in people with type 2 diabetes with normal cognition or Alzheimer's disease, and the role APOE carrier status
Che-Yuan Wu et al.
ALZHEIMERS & DEMENTIA (2020)
Glibenclamide modulates microglial function and attenuates Aβ deposition in 5XFAD mice
Yeon-Joo Ju et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Type 2 Diabetes Mellitus Drugs for Alzheimer's Disease: Current Evidence and Therapeutic Opportunities
Lei Meng et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE)
Yanyan Kong et al.
FRONTIERS IN AGING NEUROSCIENCE (2020)
Neuroprotective effects of vildagliptin on drug induced Alzheimer's disease in rats with metabolic syndrome: Role of hippocampal klotho and AKT signaling pathways
Rasha R. Yossef et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Antidiabetic Drugs for the Risk of Alzheimer Disease in Patients With Type 2 DM Using FAERS
Hayato Akimoto et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2020)
Perspective of SGLT2 Inhibition in Treatment of Conditions Connected to Neuronal Loss: Focus on Alzheimer's Disease and Ischemia-Related Brain Injury
Michal Wicinski et al.
PHARMACEUTICALS (2020)
Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease
Eugenio Barone et al.
MOLECULAR NEUROBIOLOGY (2019)
Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β
Mei Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Neuronal Calcium Sensor Dream Interactions with Insulinotropic Agent Repaglinide
Maria D. Santiago et al.
BIOPHYSICAL JOURNAL (2019)
Combined vildagliptin and memantine treatment downregulates expression of amyloid precursor protein, and total and phosphorylated tau in a rat model of combined Alzheimer's disease and type 2 diabetes
Samar S. Khalaf et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2019)
Association of metformin, sulfonylurea and insulin use with brain structure and function and risk of dementia and Alzheimer's disease: Pooled analysis from 5 cohorts
Galit Weinstein et al.
PLOS ONE (2019)
Glibenclamide ameliorates the disrupted blood-brain barrier in experimental intracerebral hemorrhage by inhibiting the activation of NLRP3 inflammasome
Fulin Xu et al.
BRAIN AND BEHAVIOR (2019)
Vildagliptine protects SH-SY5Y human neuron-like cells from Aβ 1-42 induced toxicity, in vitro
Alim Huseyin Dokumaci et al.
CYTOTECHNOLOGY (2019)
The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates High-fat Induced Cognitive Decline in Tauopathy Model Mice
Yuriko Nakaoku et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease
Christian Holscher
FRONTIERS IN AGING NEUROSCIENCE (2019)
Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease
Susan A. Farr et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Diabetes drugs in the fight against Alzheimer's disease
Virginia Boccardi et al.
AGEING RESEARCH REVIEWS (2019)
Altered Insulin Signaling in Alzheimer's Disease Brain - Special Emphasis on PI3K-Akt Pathway
Sami Gabbouj et al.
FRONTIERS IN NEUROSCIENCE (2019)
Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice
Elizabeth M. Rhea et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Neural correlates of liraglutide effects in persons at risk for Alzheimer's disease
Kathleen T. Watson et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Metformin attenuates diabetes-induced tau hyperphosphorylation in vitro and in vivo by enhancing autophagic clearance
Jin-Liang Chen et al.
EXPERIMENTAL NEUROLOGY (2019)
Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease
Ari Robinson et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2019)
Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology
Martina Holubova et al.
NEUROPHARMACOLOGY (2019)
Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting
Yao Zhang et al.
NEUROSCIENCE BULLETIN (2019)
Empagliflozin Ameliorates Type 2 Diabetes-Induced Ultrastructural Remodeling of the Neurovascular Unit and Neuroglia in the Female db/db Mouse
Melvin R. Hayden et al.
BRAIN SCIENCES (2019)
Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
Ana Marta de Matos et al.
MEDICINAL RESEARCH REVIEWS (2018)
Metformin treatment prevents amyloid plaque deposition and memory impairment in APP/PS1 mice
Zhenri Ou et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
ATP-sensitive potassium-channel inhibitor glibenclamide attenuates HPA axis hyperactivity, depression- and anxiety-related symptoms in a rat model of Alzheimer's disease
Mohammad Hossein Esmaeili et al.
BRAIN RESEARCH BULLETIN (2018)
Comparative efficacy and acceptability of antidiabetic agents for Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis
Bing Cao et al.
DIABETES OBESITY & METABOLISM (2018)
Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer's disease
Nehru Sai Suresh Chalichem et al.
JOURNAL OF DRUG TARGETING (2018)
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
Andre F. Batista et al.
JOURNAL OF PATHOLOGY (2018)
Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
Steven E. Arnold et al.
NATURE REVIEWS NEUROLOGY (2018)
GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer's disease models through the Akt/GSK-3β/β-catenin signaling
Ying Wang et al.
NEUROPHARMACOLOGY (2018)
Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis
Peng Men et al.
PLOS ONE (2018)
Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: A pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation
Eman M. Elbaz et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Metformin: An Old Drug with New Applications
Joseph Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Inhibition of the Neuronal Calcium Sensor DREAM Modulates Presenilin-2 Endoproteolysis
Rocio Naranjo et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Pioglitazone for the treatment of Alzheimer's disease
Daniela Galimberti et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease
Juan Jose Ramos-Rodriguez et al.
MOLECULAR NEUROBIOLOGY (2017)
Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease
Jayasankar Kosaraju et al.
MOLECULAR NEUROBIOLOGY (2017)
Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders
Rodrigo B. Mansur et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Astrocyte lipid metabolism is critical for synapse development and function in vivo
Anne-Lieke F. van Deijk et al.
GLIA (2017)
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial
Suzanne Craft et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Molecular Interaction of Anti-Diabetic Drugs With Acetylcholinesterase and Sodium Glucose Co-Transporter 2
Shazi Shakil
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Pioglitazone ameliorates Aβ42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3β activation
Sisi Yang et al.
MOLECULAR MEDICINE REPORTS (2017)
Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice
Shuyi Chen et al.
NEUROCHEMICAL RESEARCH (2017)
Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
Yi-Chun Kuan et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2017)
SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats
Piangkwan Sa-nguanmoo et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications
Gustavo Laine Araujo De Oliveira et al.
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2017)
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita et al.
SCIENTIFIC REPORTS (2017)
Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology
Maud Gratuze et al.
SCIENTIFIC REPORTS (2017)
Canagliflozin prevents scopolamine-induced memory impairment in rats: Comparison with galantamine hydrobromide action
Nadia M. S. Arafa et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Identification of repaglinide as a therapeutic drug for glioblastoma multiforme
Zui Xuan Xiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal
Ramesh Kandimalla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study
Aaron M. Koenig et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2017)
PPARγ agonist pioglitazone improves cerebellar dysfunction at pre-Aβ deposition stage in APPswe/PS1dE9 Alzheimer's disease model mice
Junya Toba et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Forxiga (dapagliflozin): Plausible role in the treatment of diabetes-associated neurological disorders
Sibhghatulla Shaikh et al.
BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY (2016)
The effect of the glycolipoprotein extract (G-90) from earthworm Eisenia foetida on the wound healing process in alloxan-induced diabetic rats
Golnaz Goodarzi et al.
CELL BIOCHEMISTRY AND FUNCTION (2016)
Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3β pathway in an amyloid β protein induced alzheimer disease mouse model
Liqin Qi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Metformin Facilitates Amyloid-beta Generation by beta- and gamma-Secretases via Autophagy Activation
Sung Min Son et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial
Jose A. Luchsinger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The Sur1-Trpm4 channel regulates NOS2 transcription in TLR4-activated microglia
David B. Kurland et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Metformin promotes tau aggregation and exacerbates abnormal behavior in a mouse model of tauopathy
Erica Barini et al.
MOLECULAR NEURODEGENERATION (2016)
Glimepiride protects neurons against amyloid-β-induced synapse damage
Craig Osborne et al.
NEUROPHARMACOLOGY (2016)
BRAIN INSULIN RESISTANCE AT THE CROSSROADS OF METABOLIC AND COGNITIVE DISORDERS IN HUMANS
Stephanie Kullmann et al.
PHYSIOLOGICAL REVIEWS (2016)
Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease
Henrik H. Hansen et al.
PLOS ONE (2016)
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Dalia K. Mostafa et al.
PSYCHOPHARMACOLOGY (2016)
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Michael Gejl et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Short-Term High-Fat Diet (HFD) Induced Anxiety-Like Behaviors and Cognitive Impairment Are Improved with Treatment by Glyburide
Stephen J. Gainey et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2016)
Metformin Alleviated Aβ-Induced Apoptosis via the Suppression of JNK MAPK Signaling Pathway in Cultured Hippocampal Neurons
Bin Chen et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Valentina Cappello et al.
SCIENTIFIC REPORTS (2016)
Shared Genetic Etiology between Type 2 Diabetes and Alzheimer's Disease Identified by Bioinformatics Analysis
Lei Gao et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Intranasal administration of Exendin-4 antagonizes Aβ31-35-induced disruption of circadian rhythm and impairment of learning and memory
Xiaohui Wang et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2016)
Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP/PS1 mice
Paula L. McClean et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells
Edy Kornelius et al.
CNS NEUROSCIENCE & THERAPEUTICS (2015)
Exenatide reduces TNF-α expression and improves hippocampal neuron numbers and memory in streptozotocin treated rats
Volkan Solmaz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Reduces Alzheimer Disease-Associated Tau Hyperphosphorylation in the Hippocampus of Rats With Type 2 Diabetes
Weijie Xu et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2015)
Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes
Ke Hao et al.
MOLECULAR ASPECTS OF MEDICINE (2015)
Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease
Maria Jose Perez et al.
PPAR RESEARCH (2015)
Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
Jinan Chen et al.
PLOS ONE (2015)
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease
Henrik H. Hansen et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Kir6.2 activation by sulfonylurea receptors: a different mechanism of action for SUR1 and SUR2A subunits via the same residues
Maria A. Principalli et al.
PHYSIOLOGICAL REPORTS (2015)
Metformin Treatment Alters Memory Function in a Mouse Model of Alzheimer's Disease
Kacee A. DiTacchio et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Abnormal serine phosphorylation of insulin receptor substrate 1 is associated with tau pathology in Alzheimer's disease and tauopathies
Mark Yarchoan et al.
ACTA NEUROPATHOLOGICA (2014)
Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice
Chea-Ha Kim et al.
BRAIN RESEARCH (2014)
Effects of nateglinide and repaglinide administered intracerebroventricularly on the CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice
Chea-Ha Kim et al.
BRAIN RESEARCH BULLETIN (2014)
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Bowen Lin et al.
CARDIOVASCULAR DIABETOLOGY (2014)
Invokana (Canagliflozin) as a Dual Inhibitor of Acetylcholinesterase and Sodium Glucose Co-Transporter 2: Advancement in Alzheimer's Disease-Diabetes Type 2 Linkage via an Enzoinformatics Study
Syed M. D. Rizvi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Insulin Reverses the High-Fat Diet-Induced Increase in Brain Aβ and Improves Memory in an Animal Model of Alzheimer Disease
Milene Vandal et al.
DIABETES (2014)
ATP-binding cassette transporter A1: From metabolism to neurodegeneration
Radosveta Koldamova et al.
NEUROBIOLOGY OF DISEASE (2014)
Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
LIXISENATIDE RESCUES SPATIAL MEMORY AND SYNAPTIC PLASTICITY FROM AMYLOID β PROTEIN-INDUCED IMPAIRMENTS IN RATS
H. -Y. Cai et al.
NEUROSCIENCE (2014)
Mild Cognitive Impairment and Depressive Symptoms in Elderly Patients with Diabetes: Prevalence, Risk Factors, and Comorbidity
Malgorzata Gorska-Ciebiada et al.
JOURNAL OF DIABETES RESEARCH (2014)
Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and alzheimer's disease
Enrique Blazquez et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin
Eileen M. Moore et al.
DIABETES CARE (2013)
Insulin Has Multiple Antiamyloidogenic Effects on Human Neuronal Cells
Giuseppe Pandini et al.
ENDOCRINOLOGY (2013)
DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
Noppamas Pipatpiboon et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Subcutaneous Administration of Liraglutide Ameliorates Alzheimer-Associated Tau Hyperphosphorylation in Rats with Type 2 Diabetes
Yan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
The Neuroprotection of Liraglutide on Alzheimer-Like Learning and Memory Impairment by Modulating the Hyperphosphorylation of Tau and Neurofilament Proteins and Insulin Signaling Pathways in Mice
Hui Xiong et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Inhibition of GSK3 beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes
Philip T. T. Ly et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats
Wei-Na Han et al.
NEUROBIOLOGY OF AGING (2013)
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer's Disease
Caitriona M. Long-Smith et al.
NEUROMOLECULAR MEDICINE (2013)
Saxagliptin: A dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease
Jayasankar Kosaraju et al.
NEUROPHARMACOLOGY (2013)
Chronic Treatment with the GLP1 Analogue Liraglutide Increases Cell Proliferation and Differentiation into Neurons in an AD Mouse Model
Vadivel Parthsarathy et al.
PLOS ONE (2013)
Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals
M. Bomba et al.
CELL DEATH & DISEASE (2013)
Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4
Song Chen et al.
AGE (2012)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders
Isidro Salcedo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Insulin: An Emerging Treatment for Alzheimer's Disease Dementia?
Jill K. Morris et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2012)
Long-Term Pioglitazone Treatment Improves Learning and Attenuates Pathological Markers in a Mouse Model of Alzheimer's Disease
James L. Searcy et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Hyperphosphorylation of Tau Induced by Naturally Secreted Amyloid-β at Nanomolar Concentrations Is Modulated by Insulin-dependent Akt-GSK3β Signaling Pathway
Takayoshi Tokutake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Rosiglitazone Improves Spatial Memory and Decreases Insoluble Aβ1-42 in APP/PS1 Mice
Julie-Ann O'Reilly et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease
Shweta Mandrekar-Colucci et al.
JOURNAL OF NEUROSCIENCE (2012)
PPAR? agonist pioglitazone improves scopolamine-induced memory impairment in mice
Guo Qing Xiang et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2012)
Metformin, Other Antidiabetic Drugs, and Risk of Alzheimer's Disease: A Population-Based Case-Control Study
Patrick Imfeld et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
Benjamin W. Miller et al.
ANNALS OF PHARMACOTHERAPY (2011)
A Randomized Pilot Clinical Trial of the Safety of Pioglitazone in Treatment of Patients With Alzheimer Disease
David S. Geldmacher et al.
ARCHIVES OF NEUROLOGY (2011)
Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin
Chih-Cheng Hsu et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Novel GLP-1 Mimetics Developed To Treat Type 2 Diabetes Promote Progenitor Cell Proliferation in the Brain
A. Hamilton et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease
Tomohiko Sato et al.
NEUROBIOLOGY OF AGING (2011)
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer's Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
Michael Gold et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2010)
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: A link between diabetes and Alzheimer's disease
Paula L. McClean et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
THE ROLE OF TUMOR NECROSIS FACTOR-ALPHA IN COGNITIVE IMPROVEMENT AFTER PEROXISOME PROLIFERATOR-ACTIVATOR RECEPTOR GAMMA AGONIST PIOGLITAZONE TREATMENT IN ALZHEIMER'S DISEASE
Haruo Hanyu et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease
E. M. Toledo et al.
MOLECULAR PSYCHIATRY (2010)
PIOGLITAZONE IMPROVED COGNITION IN A PILOT STUDY ON PATIENTS WITH ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT WITH DIABETES MELLITUS
Giuseppe Bellelli et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Diazoxide Reverses the Enhanced Expression of KATP Subunits in Cholinergic Neurons Caused by Exposure to Aβ1-42
Guozhao Ma et al.
NEUROCHEMICAL RESEARCH (2009)
Sulfonylurea Receptor 1 Subunits of ATP-Sensitive Potassium Channels and Myocardial Ischemia/Reperfusion Injury
David J. Lefer et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2009)
Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor γ agonist
Nektaria Nicolakakis et al.
JOURNAL OF NEUROSCIENCE (2008)
Intranasal insulin improves cognition and modulates β-amyloid in early AD
M. A. Reger et al.
NEUROLOGY (2008)
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Lin Li et al.
BRAIN RESEARCH REVIEWS (2007)
Intranasal insulin improves memory in humans: Superiority of insulin aspart
Christian Benedict et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease
M. E. Risner et al.
PHARMACOGENOMICS JOURNAL (2006)
Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice
Ward A. Pedersen et al.
EXPERIMENTAL NEUROLOGY (2006)
Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic stroke
JM Simard et al.
NATURE MEDICINE (2006)
Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype
MA Reger et al.
NEUROBIOLOGY OF AGING (2006)
Therapy Insight: type 2 diabetes mellitus and the risk of late-onset Alzheimer's disease
MN Haan
NATURE CLINICAL PRACTICE NEUROLOGY (2006)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
Increased risk of type 2 diabetes in Alzheimer disease
J Janson et al.
DIABETES (2004)
Intranasal insulin improves memory in humans
C Benedict et al.
PSYCHONEUROENDOCRINOLOGY (2004)
Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo
W Farris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Interleukin-1, neuroinflammation, and Alzheimer's disease
RE Mrak et al.
NEUROBIOLOGY OF AGING (2001)
Improving influence of insulin on cognitive functions in humans
W Kern et al.
NEUROENDOCRINOLOGY (2001)
Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis
VA Skeberdis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
